SENSIENT TECHNOLOGIES CORP — Director's Dealing 2011

Apr 21, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SENSIENT TECHNOLOGIES CORP (SXT)
CIK: 0000310142
Period of Report: 2011-04-19

Reporting Person: HOBBS RICHARD F (Senior VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-19	Common Stock	M	950	$23.00	Acquired	141422	Direct
2011-04-19	Common Stock	M	2050	$18.57	Acquired	143472	Direct
2011-04-19	Common Stock	M	6250	$24.15	Acquired	149722	Direct
2011-04-19	Common Stock	S	9250	$36.0723	Disposed	140472	Direct
2011-04-19	Common Stock	S	4000	$36.0728	Disposed	136472	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-19	Stock Options (Right to Buy)	$23.00	M	950	Disposed	2014-12-06	Common Stock (950)	Direct
2011-04-19	Stock Options (Right to Buy)	$18.57	M	2050	Disposed	2015-12-01	Common Stock (2050)	Direct
2011-04-19	Stock Options (Right to Buy)	$24.15	M	6250	Disposed	2016-12-07	Common Stock (6250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Indirect
Common Stock	0	Indirect

Footnotes

F1: Exercise of in-the-money stock option that would otherwise expire on 12/6/2014, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F2: Includes shares of restricted stock held under Issuer's 1998 and 2002 Stock Option Plans and Issuer's 2007 Restricted Stock Plan.

F3: Exercise of in-the-money stock option that would otherwise expire on 12/1/2015, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F4: Exercise of in-the-money stock option that would otherwise expire on 12/7/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F5: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $35.97 to $36.31. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $35.97 to $36.33. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.

F9: Represents shares held in Issuer's Savings Plan as of the end of the month immediately preceding this filing.

F10: Represents shares held in Issuer's Supplemental Benefit Plan as of the most recent statement date.